Skip Navigation

Advertise|Press|Contact|FAQ|CWConnect

Bookmark/Print/Share

Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Cardiology/Vascular Diseases | Psychiatry/Psychology | Pulmonary/Respiratory Diseases
Disease Category: Smoking Cessation
Location: United States, TN

Clinical Trial Details

Overview

Research Study Summary

Smoking Cessation Study

Purpose

We are currently recruiting smokers who are really motivated to quit smoking. The purpose of the study is to evaluate the safety and effectiveness of three approved medications, Habitrol, Zyban and Chantix, in combination and compared to a placebo (no active ingredient). Requires 12 weekly visits.

Patient Inclusion Criteria:

  • Participants must be 18-75 and smoke at least 10 cigarettes a day.

Patient Exclusion Criteria:

  • Patients who have had an allergic reaction to a medication, have had a DUI, seizure or stroke, are not eligible to participate. In addition, there are certain medications which would exclude the patient from participating.

To Learn more
Phase

4

Gender

Both Male and Female

Age

18 to 75 Years

Overall Status

Recruiting

Facility Type

N/A

Contact

Melissa Carro, Director of Marketing
Clinical Research Associates, Inc.
1500 Church Street
Nashville, TN 37203
Phone: 615-329-2222 ext. 304

View Map

Research Center Information: Clinical Research Associates, Inc.

If you would like to learn more about participating in this research study, please email the trial contact using the form below.

Name:
Address:
City:
State:
Zip/Postal Code:
Country:
Phone:
Email:  
Message:
 
Please leave this field empty.

CW ID: 182300

Date Last Changed: July 18, 2013


DISCLAIMER: This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.